TherapeuticsMD, Inc. 4
4 · TherapeuticsMD, Inc. · Filed Jan 8, 2014
Insider Transaction Report
Form 4
SEGAL NICHOLAS
Director
Transactions
- Award
Non-Qualified Stock Option
2014-01-06+45,000→ 298,429 total(indirect: See Footnote)Exercise: $5.05From: 2014-12-31Exp: 2024-01-06→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]Of the derivative securities, Segal owns 237,057 shares directly and 61,372 shares through 4th Generation Private Equity.